Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.14 AUD | +3.03% | +4.54% | +16.10% |
02-26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
02-25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 7.250 | 7.250 | 7.240 |
Spread/Res. | -1.52% | -1.52% | -1.38% |
Spread/Supp. | +7.21% | +36.52% | +50.32% |
Support | 6.660 | 5.230 | 4.750 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- MYX Stock
- Charts Mayne Pharma Group Limited